Results 211 to 220 of about 17,035 (272)

Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study. [PDF]

Nat Commun
Nadeem O, Aranha MP, Redd RA, Koontz M, Matous JV, Yee AJ, Zonder JA, Kin A, Magidson S, Lightbody ED, Wu T, Chabrun F, Alberge JB, Dutta AK, Perry J, Sturtevant A, Rahmat M, Tsuji J, Davie C, Ricciardi C, Arters F, Marto M, Bergeron A, Rosenblatt J, O'Donnell EK, Mouhieddine TH, Pantano L, Laubach JP, Richardson PG, Getz G, Trippa L, Sklavenitis-Pistofidis R, Ghobrial IM.   +32 more
europepmc   +1 more source

An Eosinophilic Esophagitis Endoscopic Reference Score Threshold of 2 or Less Is Robust for Assessing Endoscopic Response to Treatment of Eosinophilic Esophagitis. [PDF]

Am J Gastroenterol
Reed CC, Aleman S, Weir AA, LaFata SS, Gee TS, Lackey AR, Juneja AK, Thel HL, Cameron BA, McCallen J, Lee CJ, Hendrick GN, Bermudez JC, Song D, Redd WD, Barlowe TS, Cotton CC, Dellon ES.   +17 more
europepmc   +1 more source

Association of Deep Learning Imaging Algorithm Measures of Microbial Keratitis With Vision Outcomes. [PDF]

Cornea
Vogt EL, Niziol LM, Yang Z, Wang Y, Pawar M, Dmitriev P, Gupta AS, Armenti ST, Hood CT, Shtein RM, Kipley MM, Lee MC, Sumithra SR, Thulukanam M, Kochar P, Selvaraj S, Redd TK, Prajna NV, Farsiu S, Woodward MA.   +19 more
europepmc   +1 more source

Differences in Clinical Presentation and Treatment Response of Patients With Eosinophilic Esophagitis Complicated by Esophageal Food Impaction. [PDF]

Gastro Hep Adv
Redd WD, Barlowe TS, LaFata SS, Gee TS, Thel HL, Cameron BA, Xue AZ, Kiran A, Ocampo AA, McCallen J, Lee CJ, Borinsky SA, Kaakati RN, Cotton CC, Eluri S, Reed CC, Dellon ES.   +16 more
europepmc   +1 more source

Assessing for Disparities in Diagnostic Delay Among Patients With Eosinophilic Esophagitis. [PDF]

Clin Gastroenterol Hepatol
Redd WD, Cotton CC, Barlowe TS, Reed CC, UNC EoE Investigators, Dellon ES.   +5 more
europepmc   +1 more source

Comparative Assessment of Soil Organic Carbon Stocks in Sal (<i>Shorea robusta</i>) and Mixed Hardwood Forests of the Nepal Terai. [PDF]

Plant Environ Interact
Aryal R, Kafle G.
europepmc   +1 more source

Correction: SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities. [PDF]

PLOS Glob Public Health
Hussey H, Vreede H, Davies MA, Heekes A, Kalk E, Hardie D, van Zyl G, Naidoo M, Morden E, Bam JL, Zinyakatira N, Centner CM, Maritz J, Opie J, Chapanduka Z, Mahomed H, Smith M, Cois A, Pienaar D, Redd AD, Preiser W, Wilkinson R, Boulle A, Hsiao NY.   +23 more
europepmc   +1 more source

Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure. [PDF]

Hemasphere
Merrill MH, Redd RA, Lambert N, Caimi PF, Pullarkat P, Godby RC, Bond DA, Wehmeyer GT, Romancik J, Amoozgar B, Leslie L, Nastoupil LJ, Crombie JL, Abramson JS, Khurana A, Nowakowski GS, Maddocks K, Rutherford SC, Kahl B, Okwali M, Buege MJ, Batlevi CL, Armand P, Salles G, Qualls DA.   +24 more
europepmc   +1 more source

Pre-Exposure Prophylaxis Adherence and HIV Self-Testing App Among Women in the South Bronx: 12-Month Usability, Acceptability, and Feasibility Study. [PDF]

JMIR Form Res
Wright CG, Chern TL, Abularrage TF, Franks J, Kahn A, Edwards S, Chellani HH, Redd R, Ying AW, Arumugam S, Stanciu R, Sia SK, Morrison EA, Justman JE.   +13 more
europepmc   +1 more source

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade. [PDF]

Blood Neoplasia
Merryman RW, Kline J, Redd RA, Olszewski H, Welsh E, Pfaff K, Lee H, McDonough M, Ahn IE, Brown JR, Crombie JL, Davids MS, Fisher DC, Jacobsen ED, Jacobson CA, Kim AI, Odejide OO, Parry EM, Ryan CE, Shipp MA, Armand P, Rodig S, Abramson JS, LaCasce AS.   +23 more
europepmc   +1 more source